Alison Lloyd
Alison Lloyd | |
|---|---|
| Occupations |
|
| Academic background | |
| Alma mater | |
| Thesis | The role of intracellular signalling pathways in "ras" transformation (1989) |
| Academic work | |
| Discipline | Cell biology |
| Sub-discipline |
|
| Institutions | University College London |
Alison Clare Lloyd FMedSci is a British neurobiologist and cancer researcher. After getting her PhD at Christopher Marshall's laboratory in the Institute of Cancer Research, she started working at the University College London, where she later became Professor of Cell Biology. She was elected Fellow of the Academy of Medical Sciences in 2020.
Biography
[edit]Alison Clare Lloyd[1] was educated at University College London, where she got the Biochemistry Prize in 1984 and her BS in 1985, and the Institute of Cancer Research, where she got her PhD in 1989.[2] Her doctoral dissertation, completed in Christopher Marshall's laboratory in the Chester Beatty Laboratories, was titled The role of intracellular signalling pathways in "ras" transformation.[3][1]
Lloyd later worked as a postdoctoral fellow at Bohdan Wasylyk's laboratory at the Institut de Chimie Biologique in Strasbourg (1989–1991) and at Hartmut Land's lab at the Imperial Cancer Research Fund (1993–1997), and she was Manager of Transfer Technology of the Ludwig Institute for Cancer Research from 1991 to 1993.[2][3] In 1998, she began working at the MRC Laboratory of Molecular Biology, where she has served as a CRUK Senior Cancer Research Fellow, as the leader of a research group specialising in cell growth and tissue regeneration, and as director.[4][3][5] She became Reader at University College London in 2006 and was promoted to Professor of Cell Biology at the UCL Faculty of Life Sciences in 2009.[5]
As an academic, Lloyd specialises in neurobiology and its links to cancer.[4] The Academy of Medical Sciences described her as "a world-leading researcher on the biology and pathology of the peripheral nervous system" and "an influential member of the international Neurofibromatosis community".[4] She was elected Fellow of the Academy of Medical Sciences in 2020 for her work on neurobiology.[4]
References
[edit]- ^ a b Lloyd, Alison Clare (1989). The role of intracellular signalling pathways in "ras" transformation (Ph.D. thesis). Institute of Cancer Research. OCLC 940322466.
- ^ a b "Lloyd_Biography". Uuiversity College London. 27 July 2017. Retrieved 31 March 2024.
- ^ a b c "Oncology at the Limits 2016 | Speaker biographies". The Lancet. Retrieved 31 March 2024.
- ^ a b c d "Professor Alison Lloyd". Academy of Medical Sciences. Retrieved 31 March 2024.
- ^ a b "Alison Lloyd". University College London. Retrieved 31 March 2024.
| Authority control databases: Academics |
|---|
- Living people
- British cancer researchers
- Cell biologists
- English neuroscientists
- British women neuroscientists
- English women biologists
- British expatriate academics in France
- Academics of University College London
- Alumni of University College London
- Fellows of the Academy of Medical Sciences (United Kingdom)